HTR1A and Cognitive impairment: To investigate the involvement of 5-HT1A receptors in the attenuative effect of FLX on social and cognitive deficits, prenatal VPA mice were co-administered WAY (0.3 mg/kg, s.c.), a 5-HT1A receptor antagonist, and FLX and subjected to behavioral tests.